Publication | Open Access
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial
130
Citations
20
References
2018
Year
| Year | Citations | |
|---|---|---|
2011 | 5.3K | |
2007 | 5K | |
2017 | 3.1K | |
2008 | 2.9K | |
2016 | 2.1K | |
2007 | 2K | |
2011 | 802 | |
2008 | 725 | |
2003 | 701 | |
2018 | 506 |
Page 1
Page 1